Reaction
Immune Recovery Uveitis reporting signals
As of the last recalculation, Immune Recovery Uveitis appears in 56 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is GANCICLOVIR (PRR 1,219.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ganciclovir | 21 | 1,219.6 | 1,222.1 |
| Ganciclovir Sodium | 21 | 1,179.5 | 1,181.8 |
| Valganciclovir Hydrochloride Powder, | 13 | 515.6 | 516.2 |
| Valganciclovir | 16 | 441.2 | 441.6 |
| Valganciclovir Hydrochloride | 16 | 441.2 | 441.6 |
| Nevirapine | 7 | 329.4 | 329.7 |
| Tofacitinib Citrate | 8 | 264.4 | 264.6 |